Targeting Bcl-2 in CLL: cui bono?
Blood
.
2011 Sep 29;118(13):3453-4.
doi: 10.1182/blood-2011-08-370346.
Author
Anthony Letai
1
Affiliation
1
Dana-Farber Cancer Institute, USA.
PMID:
21960677
DOI:
10.1182/blood-2011-08-370346
No abstract available
Publication types
Comment